(IBDX) Trust - iBonds Dec 2032 - Overview
Etf: Fixed Income, Investment Grade, Corporate Bonds, Term Bonds
Dividends
| Dividend Yield | 5.27% |
| Yield on Cost 5y | 5.78% |
| Yield CAGR 5y | 28.59% |
| Payout Consistency | 98.9% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 2.66% |
| Relative Tail Risk | 0.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.86 |
| Alpha | 3.24 |
| Character TTM | |
|---|---|
| Beta | 0.081 |
| Beta Downside | 0.046 |
| Drawdowns 3y | |
|---|---|
| Max DD | 8.10% |
| CAGR/Max DD | 0.79 |
Description: IBDX Trust - iBonds Dec 2032 January 19, 2026
The iShares iBonds Dec 2032 Term Corporate ETF (IBDX) is a U.S.-based target-maturity fund that seeks to track a global corporate bond index, investing at least 80% of assets in the index’s components and a minimum of 90% in fixed-income securities that align with the index methodology.
Key metrics as of the latest reporting period include an effective duration of roughly 9.5 years, a weighted average credit rating of A- (indicating investment-grade quality), and a distribution yield near 4.2%, reflecting the fund’s focus on non-U.S. issuers and the prevailing term-structure of interest rates. The fund’s performance is especially sensitive to global corporate credit spreads and the trajectory of central-bank policy rates, with widening spreads or higher rates likely to pressure price appreciation.
For a deeper quantitative dive, consult ValueRay’s detailed analytics on IBDX’s credit-spread dynamics and projected cash-flow scenarios.
What is the price of IBDX shares?
Over the past week, the price has changed by +0.39%, over one month by +0.59%, over three months by +1.53% and over the past year by +8.84%.
Is IBDX a buy, sell or hold?
What are the forecasts/targets for the IBDX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 28.5 | 11.3% |
IBDX Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.57b USD (1.57b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.57b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.57b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.21% (E(1.57b)/V(1.57b) * Re(6.21%) + (debt-free company))
Discount Rate = 6.21% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)